Clinical trial
Clinical Study of Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells
NCT04302519 is registered in ClinicalTrials.gov with CAR-T (Shanghai) Biotechnology Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study of Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells
- Lead sponsor
- CAR-T (Shanghai) Biotechnology Co., Ltd.
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- March 5, 2020
- Completion date
- July 30, 2021
- Enrollment
- 24 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.